
EndoShape Inc Profile last edited on: 2/27/18
CAGE: 4LRD9
UEI: ZEWENXMMYDK5
Business Identifier: Minimally invasive plugs and coils for occluding blood vessels Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
5425 Airport Boulevard Suite 101
Boulder, CO 80301
Boulder, CO 80301
(303) 416-8849 |
rshandas@endoshape.com |
www.endoshape.com |
Location: Single
Congr. District: 02
County: Boulder
Congr. District: 02
County: Boulder
Public Profile
EndoShape, Inc. is is focused on delivering advances in minimally invasive medical devices through its pioneering efforts in novel shape memory polymer technologies. The firm develops polymer-based minimally invasive medical devices for peripheral vascular, nonvascular, and neurovascular indications. EndoShape utilizes patent-protected materials and products initially developed at the University of Colorado that enable it to solve key and heretofore unsolved clinical issues in the minimally invasive medical device market Organized around improving human health through the development of unique medical devices, Endoshape primary objective is to launch a new class of shape memory polymer based devices that will address minimally invasive treatment and endolumenal applications. EndoShape is seeking to improve embolization procedures for patients and physicians through the application of advanced polymer technology and unique device design.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
15-19Revenue Range
1.5M-2MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
10-14Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2021 | 1 | NIH | $123,646 | |
Project Title: Radiopaque Shape Memory Polymers for Neurovascular Embolotherapy Applications | ||||
2010 | 2 | NSF | $673,832 | |
Project Title: Shape memory polymer AAA Endograft | ||||
2009 | 2 | NSF | $624,000 | |
Project Title: Novel SMP-based TCD Devices | ||||
2009 | 1 | NSF | $100,000 | |
Project Title: Development of novel SMP-based embolic coils |
Key People / Management
Stephen Hanlon -- President and CTO
Bill Aldrich -- Chief Executive Officer
Jeff Castleberry -- COO
Stephen Goodrich
Jim Kasic
Craig Lanning
Michael Parmenter -- Director, Regulatory Affairs and Quality Assurance
Julie Trommeter
Bill Aldrich -- Chief Executive Officer
Jeff Castleberry -- COO
Stephen Goodrich
Jim Kasic
Craig Lanning
Michael Parmenter -- Director, Regulatory Affairs and Quality Assurance
Julie Trommeter